
Sudarshan Suhas Nagaonkar
About Sudarshan Suhas Nagaonkar
Data last updated:
Sudarshan Suhas Nagaonkar has 9 years in corporate governance. Holds Director role. Currently with 1 company, including Precious Life Medical Technologies Private Limited. Engaged in Technology. Contributes to corporate operations. The largest current company by reported revenue is Precious Life Medical Technologies Private Limited at ₹3.48 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Jul 2017 | 2005 | ₹3.48 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sudarshan Suhas Nagaonkar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sudarshan Suhas Nagaonkar
Sudarshan Suhas Nagaonkar has 9 years in corporate governance. Holds Director role. Currently with 1 company, including Precious Life Medical Technologies Private Limited. Engaged in Technology. Contributes to corporate operations. The largest current company by reported revenue is Precious Life Medical Technologies Private Limited at ₹3.48 Cr (FY 2025).
Sudarshan Suhas Nagaonkar is associated with 1 company as Director, including Precious Life Medical Technologies Private Limited (₹3.48 Cr).
Sudarshan Suhas Nagaonkar has expertise in Technology.
Sudarshan Suhas Nagaonkar has 9 years in corporate governance.
By reported revenue, the largest current company of Sudarshan Suhas Nagaonkar is Precious Life Medical Technologies Private Limited, with revenue of ₹3.48 Cr (FY 2025).
Sudarshan Suhas Nagaonkar currently holds positions at 1 company: Precious Life Medical Technologies Private Limited (₹3.48 Cr).